Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | THPO | P40225 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CTSD | P07339 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11695981 | 0.97 | LMNA (0.38) | CYP1A2TSHRNFKB1MAOAMAOB | |
| SCHEMBL29185897 | 0.73 | TSHR (0.37) | CYP1A2TSHRNFKB1MAOAMAOB | |
| SCHEMBL168766 | 0.69 | — | — | |
| SCHEMBL312822 | 0.69 | TSHR (0.39) | CYP1A2TSHRNFKB1MAOAMAOB | |
| SCHEMBL8045367 | 0.69 | LMNA (0.35) | CYP1A2TSHRNFKB1MAOAMAOB | |
| SCHEMBL7377614 | 0.69 | L3MBTL1 (0.42) | CYP1A2TSHRNFKB1MAOAMAOB | |
| SCHEMBL2746571 | 0.67 | — | — | |
| SCHEMBL20901908 | 0.67 | — | — | |
| SCHEMBL2996071 | 0.67 | — | — | |
| Hydrochloric Acid SCHEMBL2169126 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2552892-A1 | EFFICIENT SYNTHESIS FOR THE PREPARATION OF MONTELUKAST AND NOVEL CRYSTALLINE FORM OF INTERMEDIATES THEREIN | KRKA, D.D., Novo Mesto (SI) | 2013-02-06 | — | — | EP | disclosed |
| WO-2011121091-A1 | EFFICIENT SYNTHESIS FOR THE PREPARATION OF MONTELUKAST AND NOVEL CRYSTALLINE FORM OF INTERMEDIATES THEREIN | KRKA, D.D., NOVO MESTO (SI) | 2011-10-06 | — | — | WO | disclosed |
| EP-0983291-A4 | CARBAMATE-DERIVATIZED NUCLEOSIDES AND OLIGONUCLEOSIDES | ISIS PHARMACEUTICALS INC (US) | 2001-04-04 | — | — | EP | disclosed |
| EP-0983291-A1 | CARBAMATE-DERIVATIZED NUCLEOSIDES AND OLIGONUCLEOSIDES | ISIS PHARMACEUTICALS, INC. (US) | 2000-03-08 | — | — | EP | disclosed |
| WO-1998011123-A1 | CARBAMATE-DERIVATIZED NUCLEOSIDES AND OLIGONUCLEOSIDES | ISIS PHARMACEUTICALS, INC. (US) | 1998-03-19 | — | — | WO | disclosed |
| WO-1996010030-A1 | OLIGOMERS HAVING HETEROATOM-LINKED CONJUGATE GROUPS | ISIS PHARMACEUTICALS, INC. (US) | 1996-04-04 | — | — | WO | disclosed |